X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1686) 1686
Book Review (244) 244
Publication (130) 130
Magazine Article (4) 4
Book Chapter (3) 3
Dissertation (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1569) 1569
humans (1488) 1488
malaria (1067) 1067
female (957) 957
drug combinations (868) 868
antimalarials - therapeutic use (786) 786
sulfadoxine-pyrimethamine (681) 681
male (641) 641
tropical medicine (632) 632
antimalarials - administration & dosage (607) 607
infectious diseases (586) 586
adult (580) 580
sulfadoxine - therapeutic use (566) 566
pyrimethamine - therapeutic use (560) 560
malaria, falciparum - drug therapy (536) 536
child, preschool (514) 514
sulfadoxine - administration & dosage (505) 505
animals (492) 492
infant (491) 491
pyrimethamine - administration & dosage (489) 489
parasitic diseases (482) 482
pregnancy (463) 463
parasitology (457) 457
research (454) 454
adolescent (441) 441
child (439) 439
drug resistance (427) 427
antimalarials (411) 411
drug therapy, combination (409) 409
plasmodium falciparum (407) 407
children (371) 371
malaria - prevention & control (371) 371
malaria - drug therapy (367) 367
pyrimethamine (361) 361
plasmodium falciparum - drug effects (354) 354
drug therapy (352) 352
treatment outcome (340) 340
chloroquine (333) 333
public, environmental & occupational health (302) 302
plasmodium-falciparum malaria (293) 293
health aspects (285) 285
sulfadoxine (272) 272
efficacy (267) 267
parasites (265) 265
abridged index medicus (262) 262
prevention (252) 252
young adult (236) 236
malaria, falciparum - parasitology (229) 229
artemisinins - therapeutic use (227) 227
infectious and parasitic diseases (225) 225
vector-borne diseases (225) 225
middle aged (223) 223
antimalarials - pharmacology (218) 218
arctic medicine. tropical medicine (218) 218
plasmodium-falciparum (218) 218
artesunate (217) 217
antimalarials - adverse effects (215) 215
malaria, falciparum - epidemiology (214) 214
dosage and administration (212) 212
amodiaquine (206) 206
public health (202) 202
anemia (199) 199
artemisinins - administration & dosage (197) 197
chloroquine - therapeutic use (195) 195
pregnant women (194) 194
resistance (188) 188
care and treatment (187) 187
infant, newborn (187) 187
infections (184) 184
malaria, falciparum - prevention & control (178) 178
africa (177) 177
artemether-lumefantrine (175) 175
drug administration schedule (174) 174
pregnancy complications, parasitic - prevention & control (174) 174
malaria - epidemiology (172) 172
medicine (172) 172
plasmodium falciparum - genetics (165) 165
intermittent preventive treatment (162) 162
mefloquine (158) 158
analysis (150) 150
medicine, general & internal (149) 149
clinical trials (148) 148
mortality (147) 147
drugs (145) 145
pharmacology & pharmacy (144) 144
sulfadoxine - pharmacology (144) 144
drug dosages (143) 143
risk factors (142) 142
pyrimethamine - adverse effects (141) 141
research article (141) 141
studies (140) 140
sulfadoxine - adverse effects (140) 140
pyrimethamine - pharmacology (139) 139
women (138) 138
mutation (132) 132
preventive health services (132) 132
placebo-controlled trial (131) 131
medicine, preventive (130) 130
womens health (129) 129
plasmodium falciparum - isolation & purification (128) 128
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1618) 1618
French (37) 37
German (12) 12
Chinese (6) 6
Japanese (4) 4
Russian (3) 3
Spanish (3) 3
Bulgarian (2) 2
Italian (2) 2
Portuguese (2) 2
Dutch (1) 1
Hungarian (1) 1
Polish (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 12/2007, Volume 45, Issue 11, pp. 1453 - 1461
Background. Combination antimalarial therapy is advocated to improve treatment efficacy and limit selection of drug-resistant parasites. We compared the... 
Medical treatment failures | Relapse | Malaria | Vomiting | Articles and Commentaries | Antimalarials | Infections | Parasites | Parasitemia | Falciparum malaria | Fever | ANTIMALARIAL-DRUG | INFECTIOUS DISEASES | EFFICACY | COMBINATION THERAPY | MICROBIOLOGY | MEFLOQUINE | IMMUNOLOGY | CHLOROQUINE | CHILDREN | TRIAL | VIVAX MALARIA | TOLERABILITY | ARTESUNATE | Ethanolamines - adverse effects | Humans | Fluorenes - therapeutic use | Child, Preschool | Sulfadoxine - administration & dosage | Male | Sulfadoxine - adverse effects | Quinolines - administration & dosage | Ethanolamines - administration & dosage | Plasmodium falciparum | Pyrimethamine - administration & dosage | Sulfadoxine - therapeutic use | Amodiaquine - adverse effects | Female | Fluorenes - administration & dosage | Fluorenes - adverse effects | Amodiaquine - therapeutic use | Drug Therapy, Combination | Child | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Malaria, Falciparum - drug therapy | Pyrimethamine - adverse effects | Artemisinins - administration & dosage | Antimalarials - therapeutic use | Amodiaquine - administration & dosage | Animals | Artemisinins - therapeutic use | Burkina Faso | Antimalarials - administration & dosage | Ethanolamines - therapeutic use | Quinolines - therapeutic use | Artemisinins - adverse effects | Drug Combinations | Quinolines - adverse effects | Demographic aspects | Dosage and administration | Drug therapy, Combination | Drug therapy | Comparative analysis | Health aspects | Clinical trials | Bacteria | Nonsteroidal anti-inflammatory drugs | Index Medicus
Journal Article
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 06/2018, Volume 18, Issue 6, pp. 627 - 639
Primaquine and methylene blue are gametocytocidal compounds that could prevent transmission to mosquitoes. We aimed to assess the efficacy and safety of... 
Humans | Middle Aged | Child, Preschool | Sulfadoxine - administration & dosage | Mali - epidemiology | Quinolines - administration & dosage | Primaquine - administration & dosage | Young Adult | Malaria, Falciparum - transmission | Plasmodium falciparum | Pyrimethamine - administration & dosage | Sulfadoxine - therapeutic use | Malaria, Falciparum - epidemiology | Adult | Amodiaquine - therapeutic use | Child | Pyrimethamine - therapeutic use | Malaria, Falciparum - drug therapy | Artemisinins - administration & dosage | Amodiaquine - administration & dosage | Methylene Blue - administration & dosage | Malaria, Falciparum - parasitology | Artemisinins - therapeutic use | Primaquine - therapeutic use | Methylene Blue - therapeutic use | Adolescent | Quinolines - therapeutic use | Drug Combinations | Phosphates | Mosquitoes | Disease transmission | Malaria | Primaquine | Pyrimethamine | Clinical trials | Methylene blue | Medical services | Infections | Parasites | Drug resistance | Aquatic insects | Prevention | Reduction | Glucose dehydrogenase | Randomization | Pain | Safety engineering | Infectivity | Hemoglobin | Smear | Sulfadoxine | Technicians | Gametocytes | Safety | Glucosephosphate dehydrogenase | Drug dosages | Dihydroartemisinin | Urine | Vector-borne diseases | Bacterial infections | Effectiveness | Studies | Charities | Antimalarial agents | Amodiaquine | Community | Index Medicus
Journal Article
Malaria Journal, ISSN 1475-2875, 2007, Volume 6, Issue 1, pp. 80 - 80
Background: In view of the high level of chloroquine resistance in many countries, WHO has recommended the use of combination therapy with artemisinin... 
SULFADOXINE/PYRIMETHAMINE | BENFLUMETOL | SULFADOXINE-PYRIMETHAMINE | ARTEMETHER-LUMEFANTRINE | AMODIAQUINE | RANDOMIZED-TRIAL | MEFLOQUINE | ARTESUNATE | PARASITOLOGY | TROPICAL MEDICINE | CHILDREN | Ethanolamines - adverse effects | Follow-Up Studies | Humans | Middle Aged | Fluorenes - therapeutic use | Child, Preschool | Sulfadoxine - administration & dosage | Infant | Sesquiterpenes - administration & dosage | Sulfadoxine - adverse effects | Plasmodium falciparum - drug effects | Ethanolamines - administration & dosage | Sesquiterpenes - adverse effects | Sesquiterpenes - therapeutic use | Mefloquine - therapeutic use | Pyrimethamine - administration & dosage | Sulfadoxine - therapeutic use | Mefloquine - administration & dosage | Adult | Amodiaquine - adverse effects | Fluorenes - administration & dosage | Fluorenes - adverse effects | Amodiaquine - therapeutic use | Drug Therapy, Combination | Child | Drug Resistance | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Malaria, Falciparum - drug therapy | Pyrimethamine - adverse effects | Artemisinins - administration & dosage | Treatment Outcome | Antimalarials - therapeutic use | Amodiaquine - administration & dosage | Mefloquine - adverse effects | Animals | Artemisinins - therapeutic use | Antimalarials - administration & dosage | Senegal | Adolescent | Ethanolamines - therapeutic use | Aged | Artemisinins - adverse effects | Drug Combinations | Antimalarials | Evaluation | Dosage and administration | Drug therapy, Combination | Malaria | Drug therapy | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2016, Volume 374, Issue 10, pp. 928 - 939
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2010, Volume 54, Issue 5, pp. 1762 - 1768
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 10012, pp. 2507 - 2519
Journal Article
The Lancet, ISSN 0140-6736, 04/2019, Volume 393, Issue 10179, pp. 1428 - 1439
Intermittent treatment with sulfadoxine–pyrimethamine, recommended for prevention of malaria in pregnant women throughout sub-Saharan Africa, is threatened by... 
WOMEN | MEDICINE, GENERAL & INTERNAL | IMPACT | THERAPY | FALCIPARUM-MALARIA | EFFICACY | LOW-BIRTH-WEIGHT | MUTATION | MALAWI | AZITHROMYCIN | COMBINATION | Malaria, Falciparum - prevention & control | Double-Blind Method | Drug Administration Schedule | Humans | Artemisinins - administration & dosage | Sulfadoxine - administration & dosage | Quinolines - administration & dosage | Pregnancy | Young Adult | Antimalarials - administration & dosage | Pyrimethamine - administration & dosage | Malaria, Falciparum - epidemiology | Adult | Female | Pregnancy Complications, Parasitic - epidemiology | Pregnancy Complications, Parasitic - prevention & control | Uganda | Drug Therapy, Combination | Drug Combinations | Pregnancy Outcome | Prevention | Malaria | Pregnant women | Analysis | Pyrimethamine | Clinical trials | Antimalarials | Drug therapy | Medicine, Preventive | Obstetrics | Preventive health services | Premature birth | Stillbirth | Infections | Gestation | Parasites | Birth | Gestational age | Randomization | Motivation | Human immunodeficiency virus--HIV | Sulfadoxine | Drug dosages | Age | Dihydroartemisinin | Vector-borne diseases | Effectiveness | Anemia | Parasite resistance | Childbirth & labor | Studies | Charities | Disease transmission | Microscopy | Womens health | Birth weight | Prolongation | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Korean Medical Science, ISSN 1011-8934, 08/2014, Volume 29, Issue 8, pp. 1178 - 1181
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2011, Volume 53, Issue 8, pp. 772 - 779
Journal Article